Infectious Endocarditis Flashcards

1
Q

Definition

A

infection of the heart valves by various microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute bacterial endocarditis

A

High fevers
Systemic toxicity
Leukocytosis
Death possible within days if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Subacute bacterial endocarditis

A

Slow, indolent course associated with low-grade fevers
Night sweats
Weight loss
Vague systemic complaints
Usually in setting of previous valvular damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors for Endocarditis

A
Presence of prosthetic valve
Previous endocarditis
DM
Health-care related exposure
Congenital heart disease with cyanosis
Acquired valvular dysfunction
Hypertrophic cardiomyopathy
Mitral valve prolapse with regurgitation
Chronic IV access
IV drug abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common organisms in endocarditis

A

Staphylococcus
Streptococcus
Enterococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HACEK organisms

A
slow growing, fastidious G- bacilli
Haemophilus parainfluenzae/aphrophilus
Actinobacillus actubinycetemcomitans
Cardiobacterium hominis 
Eikenella coroodens
Kingella kingae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis for endocarditis

A

Hematogenous spread via:
Endothelial surface damaged
Sterile platelet-fibrin thrombi form on surface
Bactermia gives organisms access to and results in colonization of the endocardial surface
After colonization of endothelial surface, a “vegetation” of fibrin, platelets, and bacteria forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Complications secondary to vegetation formation

A

HF
Septic emboli
Antibody complexes can form and deposit in organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endocarditis sx

A
Fever
Schills, night sweats
Weight loss
Weakness
Malaise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endocarditis signs

A

Fever
Heart murmur
Embolic phenomenon
Skin manifestations: osler nodes, splinter hemorrhages, Janeway lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Endocarditis lab findings

A

Positive blood cultures

Nonspecific: anemia, normal/slightly elevated WBC with a mild left shift, elevated ESR or CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic tests for endocarditis

A
Transesophageal echocardiogram (TEE) is preferred
Transthoracic echocardiogram (TTE) may also be performed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Osler’s nodes

A

Purplish or erythematous subcutaneous papules or nodules on the pads of the fingers and toesl These lesions are 2-15 mm in size and are painful and tender. These nodes are not specific for infective endocarditis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Janeway’s lesions

A

Hemorrhagic, painless plaques on the palms of the hands or soles of the feet. Likely embolic in origin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Splinter hemorrhages

A

Thin, linear hemorrhages found under the nail beds of the fingers or toes; not specific for infective endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Petechiae

A

Small, erythrematous, painless, hemorrhagic lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clubbing of the fingers

A

Proliferative changes in the soft tissues about the terminal phalanges observed in long-standing endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Roth’s spots

A

Retinal infarct with central pallor and surrounding hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Peripheral manifestations of endocarditis

A
Osler's nodes
Janeway's lesions
Splinter hemorrhages
Petechiae
Clubbing of the fingers
Roth's spots
20
Q

Major Duke criteria

A

Positive blood culture (at least 2 separate)

Evidence of endocardial involvement (via diagnostic test)

21
Q

Minor Duke Criteria

A
Predisposition, predisposing heart condition or IVDU
Fever (>100.4)
Vascular phenomena
Immunologic phenomena
Microbiologic evidence
22
Q

Vascular phenomena

A

Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway’s lesions

23
Q

Immunologic phenomena

A

Glomerulonephritis
Osler’s nodes
Roth’s spots
Rheumatic factor

24
Q

Microbiologic evidence

A

Positive blood culture or serologic evidence of active infection with organism consitent with IE

25
Definitive IE
``` 2 major criteria OR 1 major criteria + 3 minor criteria OR 5 minor criteria ```
26
Possible IE
1 major criteria + 1 minor criteria OR 3 minor criteria
27
Veridans Group Streptococci, Native valve, IE therapy: PCN susceptible
``` Aqueous crystalline PCN G (12-18 mU/d) or ceftriaxone - 4 weeks OR same + gentamicin - 2 weeks OR Vancomycin - 4 weeks ```
28
Veridans Group Streptococci, Native valve, IE therapy: relative resistance to PCN
Aqueous crystalline PCN (24 mU/d) or ceftriaxone - 4 weeks + Gentamicin - 2 weeks OR Vancomycin - 4 weeks
29
Veridans Group Streptococci, Native valve, IE therapy: PCN resistant
Vancomycin + gentamicin - 6 weeks
30
Veridans Group Streptococci, Prosthetic valve, IE therapy: PCN-susceptible
Aqueous crystalline PCN (24 mU/d) or ceftriaxone - 6 weeks +/- gentamicin - 2 weeks OR Vancomycin - 6 weeks
31
Veridans Group Streptococci, Prosthetic valve, IE therapy: PCN relatively or fully resistant
Aqueous crystalline PCN G (24 mU/d) or ceftriaxone + gentamicin - 6 weeks OR Vancomycin - 6 weeks
32
Staphylococci Endocarditis, Native valve, IE therapy: MSSA
6 weeks Nafcillin/oxacillin OR If PCN allergic: cefazolin
33
Staphylococci Endocarditis, Native valve, IE therapy: MRSA
6 weeks | Vancomycin/Daptomycin
34
Staphylococci Endocarditis, Prosthetic valve, IE therapy: MRSA
Vaconmycin > 6 weeks Rifampin > 6 weeks Gentamicin - 2 weeks
35
Staphylococci Endocarditis, Prosthetic valve, IE therapy: MSSA
Nafcillin/oxacillin > 6 weeks Rifampin > 6 weeks Gentamicin - 2 weeks
36
Enterococcal endocarditis, strains susceptible to PCN, gentamicin, and vancomycin
Ampicillin or aqueous crystalline PCN G + Gentamicin (4-6 weeks) If CrCl < 50: ampicillin + ceftriaxone - 6 weeks Vancomycin + gentamicin - 6 weeks
37
Enterococcal endocarditis strains susceptible to PCN, but resistant to aminoglycosides
Ampicillin + ceftriaxone - 6 weeks
38
Enterococcal endocarditis, strains susceptible to vancomycin and aminoglycosides, but resistant to PCN
Vancomycin + gentamicin - 6 weeks
39
Enterococcal endocarditis, strains resistant to PCN, vancomycin and aminoglycosides
Linezolid or daptomycin > 6 weeks
40
Therapy for HACEK endocarditis
``` Native valves - 4 weeks Prosthetic valves - 6 weeks Ceftriaxone Ampicillin/sulbactam If pt unable to tolerate a beta-lactam: Cipro ```
41
Surgery and endocarditis
- Important adjunt to antibiotic management in certain patients - Valve removed and replaced: removes infected tissue and restores hemodynamic function - Indications: HF, persistent fever, recurrent embolic events, prosthetic valves, abscesses, ineffective abx therapy, fungal IE
42
Procedures and prophylaxis recommendations
Dental - all procedures invlolving manipulation of gingival tissue or priapical region of teeth or perforation of the oral mucosa Respiratory tract - no prophylaxis GI or GU tract - no prophylaxis Take 30-60 minutes before procedure
43
Prophylactic regimens: oral
Amoxicillin 2g
44
Prophylactic regimens: unable to take oral
Ampicillin 2g IM/IV Cefazolin 1g IM/IV Ceftriaxone 1g IM/IV
45
Prophylactic regimens: allergy to PCN - oral
Keflex 2g Clinda 600mg Azithromycin/Clarithromycin 500mg
46
Prophylactic regimens: allergy to PCN - unable to take oral
Cefazolin 1g IM/IV Ceftriaxone 1g IM/IV Clindamycin 600mg IM/IV